Aim: To make a gene diagnosis for a family with Ectodysplasin A (EDA) gene mutation as well as prenatal diagnosis, and report a novel EDA gene mutation.
Methods:
All coding sequences and flanking sequences of EDA gene were analyzed by Sanger sequencing in the proband, and then, according to EDA gene mutation in the proband, the EDA gene sequencing was performed on the family members. Based on the results above, the pathogenic mutation in EDA gene was finally identified, which was used for making prenatal diagnosis.
Results: Sanger sequencing revealed c.302_303delCC [p.Pro101HisfsX11] mutation
in EDA gene of the proband. This mutation induced EDA gene frame shift mutation which led to early termination of EDA gene translation because there was a termination codon TAA at the 11th codon behind the mutational site. Heterozygous deletion mutation (CC/--) at this locus was observed in the proband's mother and proband's grandmother, but the proband's aunt had no mutation at this locus. The analyses of amniotic fluid samples indicated negative sex-determining region on Y (SRY), and c.302_303delCC heterozygous deletion mutation.
Conclusion:
We identified a pathogenetic mutation in EDA gene for the X-linked hypohidrotic ectodermal dysplasia family, made a prenatal diagnosis for the female carrier, and reported a novel EDA gene mutation.
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| SUBJEC TS AND ME THODS
All study methods were approved by the Ethics Committee of Henan Provincial People's Hospital. All the subjects enrolled into the study gave written informed consent.
| Subjects
In July 2016, a family with suspected CED was transferred to the multidisciplinary consultation center of Henan Provincial people's
Hospital from a basic hospital for definite diagnosis and genetic counseling. The proband was a 3-year-old boy. The boy had dry skin with little sweat and without eyelashes when he was born, and exhibited intermittent fever between 36.5°C and 38.3°C during his neonatal period. In summer, his body temperature was as high as 39°C, which could be reduced to about 37°C by physical cooling but did not respond to oral antipyretic. Physical examination indicated that the boy had no teeth, but his intelligence and physical development were normal. The proband's mother had less hair from the cradle, but she had no other abnormalities. No abnormality was fond in the proband's grandmother and proband's aunt. The proband's uncle had the symptoms similar to the proband, and died 11 months after birth. Based on clinical symptoms and genetic pattern, the preliminary diagnosis of XLHED was made by the experts from stomatology, pediatrics, medical genetics institute, gynecology and obstetrics, and plastic surgery. The genealogical tree is shown in Figure 1 . We subsequently carried out gene diagnosis for the EDA gene associated with XLHED, and prenatal diagnosis.
| Specimen collection and DNA extraction
Peripheral blood (3-5 mL) was collected and mixed with EDTA-K 2 for anticoagulation in family members. Amniotic membrane puncture was performed to obtain fetal exfoliated cells from the proband's mother under ultrasound guidance. Meanwhile, the peripheral blood samples (3-5 mL) was also collected and mixed with EDTA-K 2 for anticoagulation during physical examination of new staffs of our hospital including 50 males and 50 females who had no XLHED family history and no blood relationship with this XLHED family. Total DNA of the peripheral blood and fetal exfoliated cells was extracted using Qiagen genomic DNA extraction kit (Qiagen, Germany). The DNA concentrations of normal control and samples were determined using NANODROP 2000 instrument (Thermo, USA) followed by storage at −20°C.
| Analysis of EDA gene mutation in the family by Sanger sequencing
Primers for 8 EDA exons were designed by Songon Biotech Co. Ltd (Shanghai, China) according to the EDA gene sequence, and detailed information about the sequences and primers could be found in the article. 8 PCR amplification was performed on coding sequences and flanking sequences of EDA gene, and PCR amplification products were sequenced by Songon Biotech Co. Ltd (Shanghai, China). And then, according to the mutation locus of EDA gene in the proband, the sequences at the mutation locus in EDA genes from normal males of the family and 100 healthy individuals including 50 males and 50 females were analyzed by Sanger sequencing to exclude the possibility of gene polymorphism.
| Detection of maternal cell contamination in amniotic fluid
To make sure the accuracy of results, DNA (5 ng) from the proband's mother and amniotic fluid were amplified using PowerPlex ® 
| Fetal sex diagnosis
After establishment of normal male and female control groups, as well as blank control group; the amplification of fetal sex-determining region on and 5′-GCTGGTGCTCCATTCTTG AG-3′ primers in triplicate. 
| Analysis of EDA gene mutation in the fetus by Sanger sequencing
The sequences at the mutation locus in the fetal EDA genes were analyzed by Sanger sequencing, and then, PCR product was sequenced by Songon Biotech Co. Ltd (Shanghai, China) in triplicate.
| RE SULTS

| Results of Sanger sequencing analysis
In the proband, c.302_303delCC 
| Results detected by PowerPlex ® 21 HS system
PowerPlex 21 HS system indicated that there was no maternal type in the fetal DNA typing, the fetus was female (sex chromosomes: XX), and the proband's mother as well as the fetus were in line with the maternal and daughter relationship. This suggested that there was no maternal cell contamination in the amniotic fluid specimens which might be used in future assays (Figure 3 ).
| Detection of SRY gene
Agarose electrophoresis did not show SRY gene bands amplified from the amniotic fluid samples, demonstrating that SRY gene was negative in the amniotic fluid samples, which was consistent with the results of fetal sex detected by PowerPlex 21 HS system.
| Detection of EDA gene in the fetal sample
There was c.302_303delCC heterozygous deletion mutation in the fetal EDA gene, the test was performed in triplicate, and these results were consistent in the 3 time tests (Figure 4 ). Based on above results, it was concluded that the fetus was a female XLHED carrier. 
| D ISCUSS I ON
XLHED is the most common type of ectodermal dysplasia in clinical practice. 1 Its pathogenic gene is EDA. EDA mutation and its corresponding EDA-A1 protein abnormality lead to XLHED. 10 The EDA gene was first cloned in 1996 and encodes a TNF-related ligand family type II trimer transmembrane protein which participates in intercellular signal communication during the process of ectodermal organ development. 11 To this day, about 300 species of EDA gene mutations have been reported, including EDA gene point mutation as well as splice site mutation, insertion or deletion, chromosomal changes, and so on. 12 In clinical practice, Sanger sequencing is usually used in gene test of XLHED because the length of EDA gene is short.
With the development of gene detection tools and techniques, some scholars 13 used the second generation high-throughput sequencing in EDA gene test of HED, and achieved good results. However, the second-generation sequencing has higher requirements for hardware and software of laboratories, its subsequent analysis is more complex and difficult for developing countries, and its results still need to be verified by Sanger sequencing in order to ensure the accuracy of the results. Therefore, we recommend that Sanger sequencing is directly used in EDA gene test in order to make gene diagnosis and prenatal diagnosis more economical, effective, and accurate.
In this study, based on genetic pattern and the proband's clinical symptoms, the preliminary diagnosis of XLHED was made by multidisciplinary consultation, so we used Sanger sequencing to carry out Combined with the similar mutation reported in previous literature, 21 we believe that this mutation is the cause of this disease occurring in this family. In this study, tooth eruption was not seen in the proband on his admission to the clinic; and he had got high body temperature and eyelash had not been found since he was born, which may be related to the loss of excessive C-terminal extracellular domain of EDA gene. The proband's mother presented with mild clinical symptoms of XLHED, less hair from the cradle, which may be associated with random inactivation of X chromosome. 22 However, the proband's grandmother, a XLHED carrier, had no significant clinical symptoms, suggesting that the XLHED carriers have clinical heterogeneity.
After identifying the pathogenic mutation of EDA gene in this family, we performed prenatal diagnosis for XLHED at the request of the proband's mother during mid-gestation. In prenatal diagnosis, we used the PowerPlex 21HS system to detect the maternal component in the amniotic fluid sample in order to avoid the influence of maternal contamination on the subsequent test results 23 and ensure the accuracy of the subsequent test results. Moreover, the PowerPlex 21HS system and SRY gene test could be validated mutually in the fetal sex, and the maternal and daughter relationship between the proband's mother and the fetal specimen could be confirmed by the PowerPlex 21HS system to ensure that the sample was exact. Prenatal diagnosis showed that the fetus was a female with c.302_303delCC heterozygous deletion mutation in the EDA gene, a XLHED carrier. Subsequently, we followed up the proband's mother.
The proband's mother gave birth to a female baby with Apgar score of 10 by spontaneous delivery at 39W +6 gestational weeks. The baby had hair and eyelashes at birth without hyperthermia, which was consistent with our prenatal diagnosis. We will continue to follow up the baby until her adulthood.
In this study, we first made a gene diagnosis for the XLHED family and identified the pathogenic mutation in the proband. Based on this, we further made a prenatal diagnosis for the carrier of the family, which provided reliable genetic counseling for the XLHED family.
At the same time, we report a novel pathogenic EDA gene mutation, which provides useful information for EDA gene mutation database and the relationship between EDA gene mutation and XLHED phenotype.
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